Work

Treatment beyond progression after early radiographic changes on first-line ipilimumab/nivolumab in metastatic clear cell renal cell carcinoma.

Year: 2026

Type: article

Study design: Observational Study

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.e16506

Authors: Antonio Ocejo, Andrea Knezevic, Sahil D. Doshi, Andrew E. Cornish, Ritesh R. Kotecha, Neil J. Shah, Marie Carlo, Darren R. Feldman, Robert J. Motzer, Martin H. Voss

Institutions: Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162695919

FWCI:

Cites:

Cited by:

Related to: